PROCEPT BioRobotics Reports First Quarter 2026 Financial Results
PROCEPT BioRobotics Corporation reported first quarter 2026 financial results with $83.1 million in revenue, a 20% increase year-over-year, driven by strong U.S. system sales and improved pricing. The company achieved approximately 12,200 U.S. procedures, up 30% over the prior year, and grew its U.S. install base by 40% to 765 systems. Gross margin…